CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

Ensign Peak Advisors, Inc's Holding History (CIK: 0001454984)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 275,616 Value ($000) $12,830 Avg Close $44.52 Range $38.81 - $50.98
Q3 2025
Shares 295,008 Value ($000) $12,287 Avg Close $31.97 Range $25.83 - $47.41
Q2 2025
Shares 315,564 Value ($000) $9,076 Avg Close $30.88 Range $24.10 - $34.68
Q1 2025
Shares 514,809 Value ($000) $17,267 Avg Close $37.35 Range $31.65 - $53.55
Q4 2024
Shares 502,690 Value ($000) $25,703 Avg Close $55.95 Range $49.48 - $62.53
Q3 2024
Shares 616,837 Value ($000) $31,520 Avg Close $51.57 Range $43.71 - $55.78
Q2 2024
Shares 616,227 Value ($000) $27,601 Avg Close $46.18 Range $41.01 - $53.70
Q1 2024
Shares 621,507 Value ($000) $29,093 Avg Close $39.13 Range $33.67 - $47.58
Q4 2023
Shares 435,685 Value ($000) $15,502 Avg Close $30.67 Range $25.35 - $37.88
Q3 2023
Shares 384,685 Value ($000) $11,441 Avg Close $20.61 Range $15.76 - $31.00
Q2 2023
Shares 270,269 Value ($000) $4,870 Avg Close $19.94 Range $15.50 - $24.58
Q1 2023
Shares 270,269 Value ($000) $4,341 Avg Close $18.51 Range $15.23 - $21.65
Q4 2022
Shares 270,269 Value ($000) $4,946 Avg Close $17.62 Range $15.37 - $19.97
Q3 2022
Shares 92,324 Value ($000) $1,813 Avg Close $20.39 Range $17.79 - $22.85
Q2 2022
Shares 84,624 Value ($000) $1,578 Avg Close $19.96 Range $15.91 - $27.86
Q1 2022
Shares 60,961 Value ($000) $1,338 Avg Close $20.24 Range $16.53 - $28.95
Q4 2021
Shares 34,201 Value ($000) $971 Avg Close $24.65 Range $18.97 - $28.82
Q3 2021
Shares 21,121 Value ($000) $445 Avg Close $20.92 Range $16.68 - $25.50
Q1 2020
Shares 1,104 Value ($000) $16 Avg Close $20.50 Range $10.63 - $26.67
Q4 2019
Shares 2,208 Value ($000) $55 Avg Close $19.04 Range $14.91 - $25.41